FDA Could Publish Drug GMP Data To Nudge Manufacturing Improvements
This article was originally published in The Tan Sheet
Executive Summary
Batch failure and other measures manufacturers commonly track could be aggregated into an industry-wide index FDA would use to help make inspection decisions. CDER compliance chief Howard Sklamberg says FDA wants more predictive measures to find quality issues, rather than lagging metrics such as recalls or adverse events.